Vertex Pharmaceuticals (Europe) Ltd's Net Worth
$238 Million
Who is Vertex Pharmaceuticals (Europe) Ltd?
Vertex Pharmaceuticals (Europe) Ltd has an estimated net worth of $238 Million. This is based on reported shares in CRISPR Therapeutics AG.
SEC CIK
Vertex Pharmaceuticals (Europe) Ltd's CIK is 0001761216
Past Insider Trading and Trends
2018 was Vertex Pharmaceuticals (Europe) Ltd's most active year for acquiring shares with 6 total transactions. Vertex Pharmaceuticals (Europe) Ltd's most active month to acquire stocks was the month of November. 2018 saw Vertex Pharmaceuticals (Europe) Ltd paying a total of $3,187,153.85 for 130,940 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CRISPR Therapeutics AG (CRSP) Snapshot price: $44.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.75% | 40.2K |
$24.93 | $1,002,193.68 | 5.38M |
Dec 26 - Dec 27
| |||
Form 4
| +1.73% | 90.74K |
$24.08 | $2,184,960.17 | 5.34M |
Dec 21 - Dec 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||